findmyKOL

Benjamin Ungar, MD

Basic profile

Assistant Professor of Dermatology · Icahn School of Medicine at Mount Sinai

ORCID↗NPI↗
✓ Full record
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyDermatologyFocusDermatology and Skin Diseases+4
Active KOLfindmyKOL type: EliteLatest publicationSee ScholarshipOnline presenceverified 2026Payments2021 onwardNIH fundingNot yet indexedWhy? →

Benjamin Ungar is Assistant Professor of Dermatology at Icahn School of Medicine at Mount Sinai. OpenAlex indexes 207 publications with 4,180 citations (h-index 25); ClinicalTrials.gov lists 3 registered studies matched to this name.

Overview

Updated 19 Oct 2026

Benjamin Ungar, MD, is Assistant Professor of Dermatology at Icahn School of Medicine at Mount Sinai. The public record shows 212 publications with 4,186 citations (h-index 25), centered on Dermatology and Skin Diseases, Hair Growth and Disorders, Psoriasis: Treatment and Pathogenesis. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 34 companies.

  • Most recent indexed publication: 2026 · Experimental dermatology
  • Top research focus: Dermatology and Skin Diseases
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 34 companies

Generated from the cited public record · current as of 19 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Dermatitis, Seborrheic2 trialsAlopecia2 trialsRosacea2 trialsLichen Planus1 trialAcne / Hidradenitis1 trialAcne Vulgaris1 trialKeloid1 trialAcne Keloid1 trialPsoriasis / Psoriatic ArthritisAsthmaAtopic Dermatitis / EczemaPsoriasis (Derm)

Research focus

OpenAlex concept fingerprint
Dermatology and Skin DiseasesHair Growth and DisordersPsoriasis: Treatment and PathogenesisAsthma and respiratory diseasesContact Dermatitis and Allergies

Drugs & molecules

across trials, industry payments and publications
Dupixentgeneric · DupilumabClinical trials—Industry payments99Publications7Opzelurageneric · RuxolitinibClinical trials—Industry payments17Publications1Otezlageneric · ApremilastClinical trials—Industry payments3Publications1Cosentyxgeneric · SecukinumabClinical trials—Industry payments2Publications1Xolairgeneric · OmalizumabClinical trials—Industry payments1Publications1Rinvoqgeneric · UpadacitinibClinical trials—Industry payments94Publications—Tremfyageneric · GuselkumabClinical trials—Industry payments61Publications—Skyrizigeneric · RisankizumabClinical trials—Industry payments45Publications—Sotyktugeneric · DeucravacitinibClinical trials—Industry payments45Publications—Zoryvegeneric · RoflumilastClinical trials—Industry payments44Publications—Taltzgeneric · IxekizumabClinical trials—Industry payments41Publications—Adbrygeneric · TralokinumabClinical trials—Industry payments38Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments140Lilly USA, LLCClinical trials—Industry payments73E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments57Janssen Biotech, Inc.Clinical trials—Industry payments57Arcutis Biotherapeutics, Inc.Clinical trials—Industry payments52LEO Pharma Inc.Clinical trials—Industry payments44Genzyme CorporationClinical trials—Industry payments43Pfizer Inc.Clinical trials—Industry payments43Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments39Galderma Laboratories, L.P.Clinical trials—Industry payments38Eli Lilly and CompanyClinical trials—Industry payments20Incyte CorporationClinical trials—Industry payments20Sun Pharmaceutical Industries Inc.Clinical trials—Industry payments20Dermavant Sciences, Inc.Clinical trials—Industry payments12Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments11UCB, Inc.Clinical trials—Industry payments9Janssen Scientific Affairs, LLCClinical trials—Industry payments7Icahn School of Medicine at Mount SinaiClinical trials6Industry payments—Mayne Pharma Commercial LLCClinical trials—Industry payments5Novartis Pharmaceuticals CorporationClinical trials—Industry payments4Amgen Inc.Clinical trials—Industry payments3Organon LLCClinical trials—Industry payments2Allergan, Inc.Clinical trials—Industry payments1Biofrontera Inc.Clinical trials—Industry payments1Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments1Botanix SB IncClinical trials—Industry payments1Celgene CorporationClinical trials—Industry payments1Fresenius Kabi USA, LLCClinical trials—Industry payments1Genentech USA, Inc.Clinical trials—Industry payments1Janssen Pharmaceuticals, IncClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
207publications

Distinct works indexed by OpenAlex, matched via ORCID.

4,180citations

Total citations across indexed works.

25h-index

Hirsch index (OpenAlex). i10-index 42.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
34companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1245 Madison Ave # 1047
New York, NY 10128

Telephone

212-659-9530

Provider last certified this registry record 23 Jul 2021 · collected 28 Jul 2026.

View the NPPES registry record

Clinical trials

Updated 19 Oct 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 19 Oct 2026

34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

All 83 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    26.2%
    Corticosteroid26.2%
    Clobetasol Propionate86%Hydrocortisone14%
    Part D≥69 patients

  • Cardiovascular

    21.9%
    Arteriolar Vasodilator21.9%
    Minoxidil100%
    Part D≥63 patients

  • Dermatology

    17.8%
    Interleukin-4 Receptor alpha Antagonist9.6%
    Dupixent Pen64%Dupixent Syringe36%
    Part D<11 patients
    Corticosteroid4.7%
    Triamcinolone Acetonide100%
    Part D≥19 patients

    + 2 more classes in this area

Where care is delivered (Part B)2.2% facility · 97.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Congress activity

Updated 19 Oct 2026

1 congress contribution (2023) across ASCO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 19 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 5 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
    Article697 citations2018
    doi.org ↗
  2. 02
    The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
    Article656 citations2015
    doi.org ↗
  3. 03
    RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications
    Article268 citations2015
    doi.org ↗
  4. 04
    Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
    Article262 citations2015
    doi.org ↗
  5. 05
    Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection
    Article219 citations2015
    doi.org ↗
All 207 cited works: search, sort and filter.Explore →

Network

Updated 19 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Emma Guttman‐Yassky87Nicholas Gulati49Yeriel D. Estrada36Ross O’Hagan33Divija Sharma25Joel Corrêa da Rosa22James G. Krueger21Austin J. Piontkowski20Mayte Suárez‐Fariñas19Jordan Talia18Ester DEL DUCA16Jasmine P. Levine16Ana Brânduşa Pavel15Stella A. Caldas14Sabrina Ghalili14Jónas A. Aðalsteinsson12Xiangyu Peng12Shayan Owji11Jonathan P. Ungar11Ahuva D. Cices11Hui Xu11Scott Stratman10Lillian Mo10Eden David10Jeremy N. Orloff10Camille M. Powers10Alice Tang10Brandon R. Block9Hannah Verma9Celina Dubin9Daniela Mikhaylov9Christopher J Thang9Jesús Gay-Mimbrera8Angel D. Pagan8Grace Rabinowitz8David Gárate8Maria Suprun8Miriam Mérad8Rahib K. Islam7Helen He7

Online presence

Updated 19 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/benjamin-ungar-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    clinicaltrials.gov/study/NCT07487948

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clinicaltrials.gov ↗
  • Other

    clinicaltrials.gov/study/NCT07508488

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clinicaltrials.gov ↗
  • Other

    profiles.mountsinai.org/benjamin-n-ungar

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.mountsinai.org ↗
  • Other

    scholars.mssm.edu/en/persons/benjamin-ungar

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 19 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Icahn School of Medicine at Mount Sinai (2017), graduated with distinction in research

    2017
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗
  • BA

    Harvard University, cum laude

    2009
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.mountsinai.org ↗
  • Board Certified

    American Board of Dermatology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.mountsinai.org ↗

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • Speaker

    American Academy of Dermatology (AAD) Conference 2024: New Advances in Seborrheic Dermatitis

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vumedi.com ↗
  • Regular contributor

    Dermatology Times

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dermatologytimes.com ↗
  • Author

    'Addressing the Immunological Causes of Seborrheic Dermatitis,' Patient Care Online

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →patientcareonline.com ↗
  • Author

    'The Complexities of Treating Rosacea,' Patient Care Online

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →patientcareonline.com ↗
  • Expert Roundtable Participant

    'Atopic Dermatitis,' HMP Global Learning Network

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hmpgloballearningnetwork.com ↗
  • Speaker

    Patient Care Online: Addressing the Immunological Causes of Seborrheic Dermatitis

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →patientcareonline.com ↗
  • Author

    Dermatology Times

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dermatologytimes.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”